NOV's Q1 Earnings Drop 69% but Backlog Points to 2026 Recovery

NOV reported Q1 2026 revenue that fell 2.43% from a year earlier. Operating profit dropped 69.08%, the company said. The stock has risen 20% since October and 35.5% over the past year. Investors are betting on a recovery that has not yet appeared in the income statement.

The recovery story rests on backlog execution. NOV's order book, built during the 2024–2025 upcycle, is expected to convert into revenue through 2026. That conversion should lift both top-line and margins as fixed costs are spread over higher volume. The question is timing. The first quarter showed little of that benefit.

RBC analysts downgraded NOV and Trican earlier this year, citing rising transport costs that squeeze margins. Rising Transport Costs Force RBC Downgrades of NOV and Trican The downgrade reflects a view that cost inflation will persist, delaying the margin recovery that the backlog is supposed to deliver.

Valuation is another concern. At current prices, NOV trades at a multiple that some analysts consider fair, leaving little room for error. If backlog conversion slows or costs rise further, the stock could give back its recent gains.

NOV's exposure to oil and gas drilling ties it to crude prices. crude oil profile A sustained drop in oil would reduce drilling activity and threaten the backlog's value. So far, crude has held in a range that supports current activity levels.

The 69% operating profit drop on a 2.4% revenue decline points to severe margin compression. RBC analysts attributed part of that to rising transport costs, which have not abated. NOV's own cost structure may also be under pressure from labor and materials inflation.

The market is pricing in a sharp rebound. At 20% above October levels, the stock already reflects expectations that the backlog will deliver. If Q2 shows even a modest improvement, the thesis gains credibility. If margins remain under pressure, the stock could re-rate lower.

NOV's backlog is a known quantity. The uncertainty is how much of that backlog converts at profitable margins. The company's ability to pass on cost increases to customers will determine whether the 2026 recovery materializes as the market expects.

NOV carries an Unscored Alpha Score, meaning the stock lacks a directional signal from AlphaScala's model. For a full breakdown of financials and valuation, see the NOV stock page.

The next catalyst is the pace of backlog conversion. NOV will report Q2 2026 results in a few months. That print will show whether the backlog is starting to flow through to revenue and profit. Until then, the stock is priced for a recovery that has not yet arrived.